These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 1600584)

  • 1. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults.
    Goh KT; Oon CJ; Heng BH; Lim GK
    Bull World Health Organ; 1995; 73(4):523-7. PubMed ID: 7554025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccination in children: five year booster study.
    Milne A; Krugman S; Waldon JA; Hadler SC; Lucas CR; Moyes CD; Pearce NE
    N Z Med J; 1992 Aug; 105(940):336-8. PubMed ID: 1508451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of hepatitis B vaccine in a simplified immunization programme.
    Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I
    Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
    Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, reactogenicity and comparison of two doses of recombinant DNA yeast-derived hepatitis B vaccine in Ethiopian children.
    Tsega E; Tafesse B; Horton J; Nordenfelt E; Wolde-Hawariat G; Hansson BG; Lindberg J
    Trop Geogr Med; 1991; 43(1-2):220-7. PubMed ID: 1836290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the status of immune memory after completion of hepatitis B vaccination].
    Li YP; Li RC; Fang KX; Li HM; Hu ZY; He P; Wu XY; Zhang R; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Apr; 28(4):319-21. PubMed ID: 17850693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
    Jafarzadeh A; Montazerifar SJ
    J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
    Milne A; Moyes CD; Dimitrakakis M
    N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children].
    Liang Z; Li C; Jing Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):165-7. PubMed ID: 10322792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization].
    Li H; Li R; Liao S; Yang J; Zeng X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Feb; 20(1):54-9. PubMed ID: 11367735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a recombinant, yeast-derived, anti-hepatitis-B vaccine after alternative dosage and schedule vaccination in Pakistani children.
    Akram DS; Maqbool S; Khan DS; Jafri R; Randhawa S; Valenzuela-Silva C; Lopez-Saura P
    Vaccine; 2005 Dec; 23(50):5792-7. PubMed ID: 16303217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatitis B in children in a high risk New Zealand community, and control using recombinant DNA vaccine.
    Milne A; Heydon JL; Hindle RC; Pearce NE
    N Z Med J; 1989 Apr; 102(866):182-4. PubMed ID: 2523525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose hepatitis B vaccination in children.
    Milne A; Allwood GK; Pearce NE; Lucas CR; Krugman S
    N Z Med J; 1986 Feb; 99(795):47-9. PubMed ID: 2935755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.